Backgrounds Limited evidence is available regarding pharmacist managed anticoagulation clinic in the Southeast Asian region where there is marked difference in terms of care model, genetic composition and patient demographics. Objectives This study aimed at comparing the anticoagulation clinic managed by the pharmacist with physician advisory and the usual medical care provided in Kuala Lumpur Hospital (KLH) in terms of anticoagulation control and adverse outcomes. Setting A 2,302 bedded government tertiary referral hospital in Malaysia. Methods A 6-month retrospective cohort study of the effectiveness of two models of anticoagulation care, the pharmacist managed anticoagulation clinic which is known as warfarin medication therapy adherence clinic (WMTAC) and usual medical clinic (UMC) in KLH was conducted, where a random number generator was used to recruit patients. The UMC patients received standard medical care where they are managed by rotational medical officers in the physicians’ clinic. As for the WMTAC with physician advisory, the pharmacist will counsel and review the patients internationalised normalization ratio at each clinic visit and also adjust the patients’ warfarin dose accordingly. Patients are referred to physicians if immediate attention is required. Main outcome measure The main therapeutic outcome is time in therapeutic range (TTR) both actual and expanded TTR and thromboembolic and bleeding complications. Results Each of the WMTAC and usual medical care recruited 92 patients, which totals to 184 patients. The patient demographics in terms of age, race and indication of treatment were comparable. At the end of the 6 months follow-up, patients in the WMTAC group had significantly higher actual-TTR (65.1 vs. 48.3 %; p < 0.05) compared to those in usual medical care group. Rates of admission were 6.5 versus 28.2 events per 100 person-years for the WMTAC and UMC groups, respectively. Though the bleeding incidences were not significantly different, it was reduced. Conclusions These findings will impact local warfarin patient management services and policies because there was no available evidence supporting the role of pharmacists in the management of warfarin patients prior to this study.
Anticoagulation clinic Malaysia Pharmacists Therapeutic range Warfarin
This is a preview of subscription content, log in to check access.
We would like to acknowledge and thank the Kuala Lumpur Hospital for granting permission to use the hospital and its resources to conduct this study. We gratefully acknowledge all of the hospital staff who contributed to the study and DAWN Clinical Software for the AC software used to provide the percentage of time within the therapeutic range calculations.
The research is funded by the University Sains Malaysia, Research University Grant. The author is sponsored by the Federal Training Grant, Ministry of Health for post-graduate research.
Wysowski DK, Nourjah P, Swartz L. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med. 2007;167(13):1414–9.PubMedCrossRefGoogle Scholar
Saokaew S, Permsuwan U, Chaiyakunapruk N, Nathisuwan S, Sukonthasarn A. Effectiveness of pharmacist-participated warfarin therapy management: a systematic review and meta-analysis. J Thromb Haemost. 2010;8(11):2418–27.PubMedCrossRefGoogle Scholar
Sullivan PW, Arant TW, Ellis SL, Ulrich H. The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US. Pharmacoeconomics. 2006;24(10):1021–33.PubMedCrossRefGoogle Scholar
Bungard TJ, Gardner L, Archer SL, Hamilton P, Ritchie B, Tymchak W, et al. Evaluation of a pharmacist-managed anticoagulation clinic: Improving patient care. Open Med. 2009;3(1):e16–21.PubMedGoogle Scholar
Donovan JL, Drake JA, Whittaker P, Tran MT. Pharmacy-managed anticoagulation: assessment of in-hospital efficacy and evaluation of financial impact and community acceptance. J Thromb Thrombolysis. 2006;22(1):23–30.PubMedCrossRefGoogle Scholar
You JH, Chan FW, Wong RS, Cheng G. Cost-effectiveness of two models of management for patients on chronic warfarin therapy—a Markov model analysis. Thromb Haemost. 2003;90(6):1106–11.PubMedGoogle Scholar
Saokaew S, Sapoo U, Nathisuwan S, Chaiyakunapruk N, Permsuwan U. Anticoagulation control of pharmacist-managed collaborative care versus usual care in Thailand. Int J Clin Pharm. 2012;34(1):105–12.PubMedCrossRefGoogle Scholar
Choe H, Kim J, Choi K, Mueller B. Implementation of the first pharmacist-managed ambulatory care anticoagulation clinic in South Korea. Am J Health-Syst Pharm. 2002;59(9):872–4.PubMedGoogle Scholar
Chan FW, Wong RS, Lau WH, Chan TY, Cheng G, You JH. Management of Chinese patients on warfarin therapy in two models of anticoagulation service—a prospective randomized trial. Br J Clin Pharmacol. 2006;62(5):601–9.PubMedCrossRefGoogle Scholar
Kong MC, Ng HJ, Lee PL, Chan YH, Tan D, Lee LH. Implementation and impact of a hybrid pharmacist-assisted anticoagulation clinic model on the quality of anticoagulation therapy. Clin Appl Thromb Hemost. 2012;18(3):334–7.PubMedCrossRefGoogle Scholar
Fretheim A, Oxman AD. International variation in prescribing antihypertensive drugs: its extent and possible explanations. BMC Health Serv Res. 2005;5(1):21.PubMedCrossRefGoogle Scholar
Government of Malaysia. Pekeliling Perkhidmatan. In: Malaysia PSDo, editor. Putrajaya; 2007. p. 1–545.Google Scholar
Medication Therapy Adherence Clinic. Warfarin. First Edition 2010. Kuala Lumpur: Perpustakaan Negara Malaysia; 2010.Google Scholar
Hirsh J, Dalen J, Anderson DR, Poller L, Bussey H, Ansell J, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 2001;119(1 Suppl):8S–21S.PubMedCrossRefGoogle Scholar
Wilson SJ-A, Wells PS, Kovacs MJ, Lewis GM, Martin J, Burton E, et al. Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. Can Med Assoc J. 2003;169(4):293–8.Google Scholar
Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69(3):236–9.PubMedGoogle Scholar
Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of chest physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6 Suppl):160S–98S.PubMedCrossRefGoogle Scholar
Chamberlain MA, Sageser NA, Ruiz D. Comparison of anticoagulation clinic patient outcomes with outcomes from traditional care in a family medicine clinic. J Am Board Fam Pract. 2001;14(1):16–21.PubMedGoogle Scholar
Hwang JM, Clemente J, Sharma KP, Taylor TN, Garwood CL. Transportation cost of anticoagulation clinic visits in an urban setting. J Manag Care Pharm. 2011;17(8):635–40.PubMedGoogle Scholar
Young S, Bishop L, Twells L, Dillon C, Hawboldt J, O’Shea P. Comparison of pharmacist managed anticoagulation with usual medical care in a family medicine clinic. BMC Fam Pract. 2011;12(88):1471–2296.Google Scholar
Poon IO, Lal L, Brown EN, Braun UK. The impact of pharmacist-managed oral anticoagulation therapy in older veterans. J Clin Pharm Ther. 2007;32(1):21–9.PubMedCrossRefGoogle Scholar
Thanimalai S CT, Ariffin F, Chan CK, Chan BS, Chong SH, Heng SY. Achieving INR targets and improving satisfaction of Warfarinized patients, Kuala Lumpur Hospital. J Quality Improvement. 2010;2:50–67 [Original Article].Google Scholar
Cindy J, Guy L. Enhancing patient care via a pharmacist-managed rural anticoagulation clinic. Healthc Q. 2009;13(Sp):69–74.CrossRefGoogle Scholar
Lodwick AD, Sajbel TA. Patient and physician satisfaction with a pharmacist-managed anticoagulation clinic: implications for managed care organizations. Manag Care. 2000;9(2):47–50.PubMedGoogle Scholar
Jowett S, Bryan S, Mahe I, Brieger D, Carlsson J, Kartman B, et al. A multinational investigation of time and travelling costs in attending anticoagulation clinics. Value Health. 2008;11(2):207–12.PubMedCrossRefGoogle Scholar
Wan Y, Heneghan C, Perera R, Roberts N, Hollowell J, Glasziou P, et al. Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review. Circ Cardiovasc Quality Outcomes. 2008;1(2):84–91.CrossRefGoogle Scholar
Rudd KM, Dier JG. Comparison of two different models of anticoagulation management services with usual medical care. Pharmacotherapy. 2010;30(4):330–8.PubMedCrossRefGoogle Scholar